Feasibility and Psychometric Properties of the Recovery Assessment Scale (RAS) in People with Mental Illness for Its Use in Argentina

Zalazar, Virginia; Valdez, Joaquín Castro; Mascayano, Franco; Vera, Norha; Scorza, Pamela; Agrest, Martín

doi:10.1007/s40737-017-0098-5

Cited by 11 publications

(11 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…High scores suggest a more advanced recovery process. The RAS-21 presents adequate evidence of reliability and validity [39], has been translated in Spain by Muñoz et al (2011), and Zalazar et al (2017) examined the psychometric properties of this instrument in Argentina [45,46].…”

Section: Methodsmentioning

confidence: 99%

Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia

et al. 2021

View full text Add to dashboard Cite

The aim of this study was to evaluate the effects of adherence to antipsychotic treatment on the recovery of patients with schizophrenia in northern Chile. One hundred and fifty-one patients diagnosed with schizophrenia completed the Drug Attitude Inventory (DAI-10), Positive and Negative Syndrome Scale for Schizophrenia (PANSS), Recovery Assessment Scale (RAS-24), sociodemographic information, and clinical and treatment characteristics of patients with schizophrenia. Multivariate analysis with multiple linear regression was then performed to identify variables that were potentially associated with the recovery assessment (variable criterion). A significant association was found between adherence to antipsychotic medication and the Willing to Ask for Help dimension of Recovery (β = 0.239, p = 0.005). Association of clinical and socio-demographic variables with recovery were identified: negative symptoms with Personal Confidence and Hope (β = −0.341, p = 0.001) and Goal and Success Orientation (β = −0.266, p = 0.014); cognitive symptoms with Willing to Ask for Help (β = −0.305, p = 0.018) and no domination by symptoms (β = −0.351, p = 0.005); marital status with reliance on others (β = −0.181, p = 0.045); age with Personal Confidence and Hope (β = −0.217, p = 0.021), Goal and Success Orientation (β = −0.296, p = 0.003), and no domination by symptoms (β = 0.214, p = 0.025). Adherence has a positive relationship with personal recovery in this sample of Chilean patients with schizophrenia.

show abstract

Section: Methodsmentioning

confidence: 99%

Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The RAS is a widely validated scale which includes the assessment of five different recovery factors for people with SPMI, with a special focus on hope and self-determination. In addition, this test has been previously validated and adapted to Spanish [ 37 , 38 ]. The RAS includes 41 items, uses a 5-point Likert scale that ranges from 1 = “totally disagree” to 5 = “totally agree” and groups these items into five factors: personal confidence and hope (e.g., “I have a purpose in life”); willingness to ask for help (e.g., “I ask for help when I need it”); goal and success orientation (e.g., “I have a desire to succeed”); reliance on others (e.g., “I have people I can count on”); and not being dominated by symptoms (e.g., “My symptoms interfere less and less in my life”).…”

Section: Methodsmentioning

confidence: 99%

Spirituality and Employment in Recovery from Severe and Persistent Mental Illness and Psychological Well-Being

et al. 2021

View full text Add to dashboard Cite

People diagnosed with severe and persistent mental illness (SPMI) face multiple vulnerabilities, including when seeking employment. Among SPMI patients, studies show that a stronger sense of spirituality can help to reduce psychotic symptoms, increase social integration, reduce the risk of suicide attempts and promote adherence to psychiatric treatment. This study examined how the variables spirituality and employment affect the recovery process and psychological well-being of people with SPMI who attend employment recovery services. The sample consisted of 64 women and men diagnosed with an SPMI. The assessment instruments included the Recovery Assessment Scale, Ryff Psychological Well-Being Scale, Work Motivation Questionnaire, Daily Spiritual Experience Scale, and Functional Assessment of Chronic Illness Therapy—Spiritual Well-Being (FACIT-Sp12). Hierarchical regression analyses were performed to compare three different models for each dependent variable (recovery and psychological well-being). The findings showed that job skills predicted psychological well-being and recovery. When spiritual variables were included in the model, job skills dropped out and the dimension meaning/peace of the FACIT-Sp12 emerged as the only significant predictor variable. Integrating spirituality into recovery programs for people with SPMI may be a helpful complement to facilitate the recovery process and improve psychological well-being.

show abstract

“…The RAS-24 presents adequate evidence of reliability and validity and is probably the most widely used measure of recovery in research (Salzer and Brusilovskiy, 2014;Van Eck et al, 2018). The RAS-24 has been translated into Spanish by Muñoz et al (2011), andZalazar et al (2017) examined the psychometric properties of this instrument in Argentina.…”

Section: Recovery Assessment Scale (Ras-24)mentioning

confidence: 99%

Psychosocial Effects of the COVID-19 Pandemic on Patients With Schizophrenia and Their Caregivers

et al. 2021

View full text Add to dashboard Cite

The aim of this study was to analyze the psychosocial effects of the COVID-19 pandemic on 120 patients with schizophrenia, and their caregivers (control group), in the city of Arica, northern Chile. The hypotheses of this study hold that (1) self-reports of the impact of the COVID-19 pandemic among patients and caregivers would be positively correlated, (2) caregivers would self-report a greater impact of the pandemic on their daily lives, and (3) patients infected with COVID-19 would experience lower levels of mental health improvement and higher levels of psychological distress. Hypotheses were tested using correlations, mean differences, and effect sizes (Cohen’s d). The results showed that patients with schizophrenia who had been in quarantine for almost a year showed similar levels of concern as their caregivers in the domains of health and social life. However, caregivers showed significant differences from patients in the areas of income, concern, and employment status. In addition, patients who were infected with COVID-19 showed lower levels of well-being and worse psychological recovery. The implications of the findings highlight the need to incorporate mental health interventions in the pandemic health context for caregivers of people with schizophrenia. Finally, the results suggest that Covid-19 infection has a significant effect on the recovery and psychological well-being of patients with schizophrenia.

show abstract

Feasibility and Psychometric Properties of the Recovery Assessment Scale (RAS) in People with Mental Illness for Its Use in Argentina

Cited by 11 publications

References 38 publications

Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia

Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia

Spirituality and Employment in Recovery from Severe and Persistent Mental Illness and Psychological Well-Being

Psychosocial Effects of the COVID-19 Pandemic on Patients With Schizophrenia and Their Caregivers

Contact Info

Product

Resources

About